This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://dx.doi.org/10.1023/A:
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73535629
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в травні 1997 article scientifique publié en 1997 artículu científicu espublizáu en mayu de 1997 im Mai 1997 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel scientific article published on 01 May 1997
p:P577
wds:Q73535629-D8E2E133-EC5F-4AF4-9DA0-DCD8C5666B14
wdt:P577
1997-05-01T00:00:00Z
p:P2860
wds:Q73535629-9E8A6589-60F7-4C1C-A62D-142778C372D9 wds:Q73535629-617B361C-9F7A-4BDD-B424-8970BBEE4CE3 wds:Q73535629-DF9542DF-D1A8-402E-9BA0-F2A6B281441B wds:Q73535629-E1B76D98-3048-4864-AD79-6FC7E9A01D26
wdt:P2860
wd:Q39199135 wd:Q43969585 wd:Q40423816 wd:Q38184652
p:P2093
wds:Q73535629-5F61A962-33E6-437D-8153-2B2314907977 wds:Q73535629-584B0D87-79C2-45FE-9919-CC4F1AC7A450 wds:Q73535629-DF593535-277B-476D-B2E5-258BF58CFAC9 wds:Q73535629-EC8A6236-2896-49E9-922E-E54B1B96C8B4 wds:Q73535629-D94E4D7A-03A1-46A2-90C5-8809199BEE9E wds:Q73535629-A2FE70E7-A0FE-432D-A7D8-5CB5EC5DC88F
wdt:P2093
D Kerr E François M Ducreux P Rougier L Seymour A Adenis
rdfs:label
A phase II study of raltitrexed A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma
skos:prefLabel
A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma A phase II study of raltitrexed
schema:name
A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma A phase II study of raltitrexed
p:P50
wds:Q73535629-125E48D9-E377-4D52-B81F-B5EAD8B1C87A
wdt:P50
wd:Q46469728
p:P1476
wds:Q73535629-3713C2AE-73F3-49EC-ADC2-51BBE70EDC1B
wdt:P1476
A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma
p:P304
wds:Q73535629-44E158BF-C41C-4835-8C39-EF8697A97A44
wdt:P304
500-502
p:P31
wds:Q73535629-D834F373-37A4-41BB-9EFE-05418C1E4990
wdt:P31
wd:Q13442814
p:P921
wds:Q73535629-2D100E6D-11D2-4505-9C22-447A70449A53
wdt:P921
wd:Q1148337
p:P698
wds:Q73535629-85A6F322-A9FE-426E-A041-31D455A2217D
wdtn:P698
n8:9233532
wdt:P698
9233532
p:P1433
wds:Q73535629-EEFE3C6C-607B-4355-9710-EA285E7B286F
wdt:P1433
wd:Q326122
p:P433
wds:Q73535629-86F7E0F7-593C-48B4-B081-1B36A62E9B37
p:P478
wds:Q73535629-86B48F4C-BF22-4658-BDB7-F611FF0A6ED4
wdt:P433
5
wdt:P478
8
p:P356
wds:Q73535629-DE5C2F80-CBA0-4B35-9FE4-B4382825A76D
wdtn:P356
n10:1008249328792
wdt:P356
10.1023/A:1008249328792